People · Operator
Named in public records as an officer, director or promoter · active 2011–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Access Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $39.2M | $423.2M | 2011 |
Steven H. Rouhandeh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Steven H. Rouhandeh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark J Ahn | 1 | 3 |
| Jeffrey B. Davis | 1 | 2 |
| Todd B. Wider | 1 | 2 |
| Jeffrey H. Davis | 1 | 1 |
| Mark J. Alvino | 1 | 1 |
| Stephen B. Thompson | 1 | 1 |
| Todd B. Widder | 1 | 1 |
| Stephen B. Howell | 1 | 1 |
| Tim B. Miller | 1 | 1 |
| Stephen B. Howell, M.D. | 1 | 1 |
| Mark J. Ahn, Ph.D. | 1 | 1 |
| Esteban H. Cvitkovic, M.D. | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.